Understanding the Distribution Process of COVID-19 Vaccines
Financial loss can often be forecasted and mitigated, but if a business experiences an unfortunate event that negatively affects its reputation, the effects can be devastating and even lead to closure.
Last month, the UK became the first western nation to authorise a COVID-19 vaccine. Since then, the government has secured a total 357 million doses of vaccines from seven different developers. But, while help is on the way, it will still take time to distribute enough vaccines to allow life to return to the way it was before the coronavirus pandemic.
Employers should take the time to familiarise themselves with the government’s plans regarding the vaccine’s distribution. Organisations should also be prepared to accommodate the needs of employees and adjust overall operations accordingly.
Health care and social care workers will be prioritised for receiving a COVID-19 vaccine. Additionally, those living or working in a care home for adults will also be given the first jabs. Following those groups, the vaccine will be prioritised for older people, NHS-shielded patients and those with long-term conditions.
What to Expect
Employees who receive a COVID-19 vaccine may experience side effects that could have short-term impacts on their ability to perform their normal duties. These side effects might include:
- Pain, a heavy feeling or tenderness in the arm where the jabs were received
- General aches or mild flu-like symptoms
The distribution of COVID-19 vaccine is a monumental moment. Organisations should take time to consider how the ongoing distribution of COVID-19 vaccines may affect their employees and make necessary accommodations to make this process as smooth as possible.